开元官网登录入口

Nanchang, China – On November 3, 2022, the 2022 Robotic and Minimally Invasive Urological Surgery Forum & the 2^nd Annual Academic Conference of the Laparoscopic and Robotic Surgery Branch of the China Anti-Cancer Association & the 5^th Session of the Urology Branch of the Jiangxi Integrative Medicine Association, organized by the Jiangxi Integrative Medicine Association and hosted by the Urology Department of the First Affiliated Hospital of Nanchang University, kicked off in Nanchang, Jiangxi Province. The three-day, tightly scheduled event was attended by hundreds of urologists from all over China both online and offline, who witnessed this academic feast focusing on the current situation and future trends of urological robots.

The MicroPort^® Toumai^® Laparoscopic Surgical Robot made its first live debut and showed the training session at the conference, presenting to all the participants the cutting-edge experience and achievements of domestic robots in terms of clinical technology and training. On the first day of the conference (November 3), the "Ganjiang Phase II" MicroPort^® Toumai^® Laparoscopic Surgical Robot Urology Surgery Training Course was successfully held. On the third day, Shuo Wang, Director of the Urology Department of the First Affiliated Hospital of Zhejiang University School of Medicine, successfully performed a live streaming of the radical prostatic cancer surgery completed through the extraperitoneal approach with the help of Toumai^®, which was also the first surgical live streaming performed by Toumai^®. This fully demonstrates that Toumai^® has been sophisticated in assisting surgeons to carry out challenging procedures with its stable, safe, and efficient performance.

The opening ceremony of the conference was held on the morning of November 5, attended by numerous experts and leaders, including Mr. Xiaoping Chen, academician of the Chinese Academy of Sciences and honorary chairman of the Laparoscopic and Robotic Surgery Branch of the China Anti-Cancer Association, Prof. Jian Huang, chairman of the Urology Branch of the Chinese Medical Association, Mr. Xu Zhang, academician of the Chinese Academy of Sciences and chairman of the Laparoscopic and Robotic Surgery Branch of the China Anti-Cancer Association, Prof. Minhua Zheng, chairman-elect of the Laparoscopic and Robotic Surgery Branch of the China Anti-Cancer Association, Prof. Youwen Tan, the Party secretary of the First Affiliated Hospital of Nanchang University, Prof. Wei Zhang, president of the First Affiliated Hospital of Nanchang University, Prof. Gongxian Wang, vice chairman of the Robotics Group of the Urology Branch of the Chinese Medical Association, and Prof. Ting Sun, chairman of the Urology Branch of the Jiangxi Medical Association, during which they also delivered speeches.

Under the witness of the chairmen of the conference, the "Academician Xu Zhang’s workstation" was officially inaugurated, marking a milestone of the First Affiliated Hospital of Nanchang University in promoting the urology discipline and putting the guiding principles from our 20^th National Congress into action by attaching strategic importance to safeguarding people's health, so as to further empower the "Healthy China" initiative.

Throughout the day, experts shared multiple urological robotic surgery cases via demonstration and live streaming. Clinical skills, surgical experience, and research results were under heated discuss, comprising the radical prostate cancer surgery, the partial nephrectomy, and the percutaneous nephrolithotripsy, which benefited the attendees profoundly as if they had been standing at the operating table.

In the demonstration session, multiple domestic robots pitted against and learned from each other with a focus on the "radical prostate cancer surgery", and the Toumai^® Laparoscopic Surgical Robot made a stunning debut operated by Prof. Shuo Wang, director of Urology Department of the First Affiliated Hospital of Zhejiang University School of Medicine. The patient was an elderly man with a large prostate, whose Gleason score was 3+4=7, making it more difficult to carry out surgical freeing and exposure. Director Wang chose to perform the surgery via the extraperitoneal approach and demonstrated the whole procedures with text-book standards to the attendees. The live streaming was also the national debut of the Chinese-developed four-arm Toumai^® Laparoscopic Surgical Robot, which has now been registered.

Director Shuo Wang performed the surgery carefully while explaining the procedures to the attendees, who could witness via high-definition live streaming that Director Wang skillfully used the robot’s seven flexible free joints to conduct surgical freeing, dissection, division, and anastomosis in the narrow extraperitoneal space. Although the space for the radical prostate cancer surgery via the extraperitoneal approach is somewhat more limited than the transabdominal radical prostate cancer surgery, it is safer because there is no interference from intra-abdominal organs, leading to a quicker recovery for patients. Director Shuo Wang preserved the patient’s urethra as much as possible and completed the urethral suture reconstruction, which is more conducive to the patient’s urinary control after the surgery. He mentioned the impressive performance of Toumai^® in suturing and praised its ability to carry out a precise suturing to stop bleeding and a precise suture reconstruction in the narrow space. After completing the urethral reconstruction, Director Shuo Wang removed the external-iliac lymph node near the blood vessels on both sides.

At the end of the surgery, Xu Gao, director of the Urology Department of Changhai Hospital in Shanghai, also commented on the robot’s performance, saying that he started to use Toumai^® several years ago, and now he saw the significant improvement in its technical precision, which, combined with Director Shuo Wang’s superb clinical skills, has delivered tangible benefits to patients. Despite an uphill, arduous journey ahead, there is still room for technological improvement and upgrading for domestic robots that leads to a promising future. We are fully convinced that aided by intelligent technologies, more benefits and blessings will be brought to patients.

Director Shuo Wang said that with the assistance of the Chinese-developed Toumai^®, it is absolutely possible to complete challenging urological surgeries. He looked forward to the continuous advancement of domestic intelligent manufacturing to render service to more patients, so that Chinese-developed robots will ultimately become popular in the operating rooms through the close-knit cooperation between surgeons and research teams.

On the afternoon of  November 3, the first day of the conference, the "Ganjiang Phase II" MicroPort^® Toumai^® Robot Urology Surgery Training Course was held as scheduled, and Prof. Gongxian Wang, vice chairman of the Robotics Group of the Urology Branch of the Chinese Medical Association, attended the course and delivered a speech.

He said that surgical robotic devices have become an irresistible trend in the development of science and technology in the world, precisely like the transformation from open operations to laparoscopic surgeries, which is an inevitable medical progress. The intelligent surgical robot can perform complex knotting operations with the aid of a magnified field of view even in a tiny, narrow space. This helps the realization of making surgeries minimally invasive. We highly anticipate the continuous sessions of the MicroPort^® Toumai^® Laparoscopic Surgical Robot Urology Surgery Training Course nationwide, which will continue to translate the advanced technology of the MicroPort^® MedBot^® robotics into clinical practice, working together with surgeons of urology and other departments to build their capacity in medical fields.

During the training course, the trainer of Toumai^® explained the basic operation of Toumai^® systematically and introduced the robotic equipment, instruments, and fittings in detail. After experiencing the operation of the Surgeon Console, the Patient Cart, and the Vision Cart through the test drive, the trainees understood the essentials of surgical operation and the use of instruments, saying that they benefited greatly and marveling at the exquisite, stable performance of the Chinese-developed  robot.

Through modular exercises and in vitro organ simulation exercises, the trainees were immersed in the flexible, sophisticated robotic arms. During the group study, they were enthusiastic about the test drive and impressed by the 3D high-definition field of view of Toumai^® when performing operation drills at the console in turn. Everyone looked forward to mastering the key points of robotic clinical surgeries in greater details to carry out urological surgeries better in the future.

During the three-day event, the Toumai^® Booth attracted more than 100 experts and scholars, and many surgeons were interested in test-driving the robot, who acclaimed and applauded Toumai^®’s tissue magnification and highly free simulation wrists. They said that domestic intelligent manufacturing has kept making breakthroughs in catching up with foreign advanced technologies and solving a series of the stranglehold issue through independent innovation. They also expected that national enterprises can launch more safe, reliable, and practical robots to offer "powerful tools" for surgeons.

Mr. Yu Liu, Executive Vice President and Chief Commercial Officer of MicroPort^® MedBot^®, said, "The success of ‘Ganjiang Phase II’ training course marked a further step in medical-engineering cooperation and clinical transformation of Toumai^®. We will insist on running the training sessions, so that Toumai^® can reach more hospitals and surgeons to boost the building of regional urology disciplines and related services. The first live streaming of Toumai^® was a success, and we hope to dig and delve deeper into domestic robots in performing routine and challenging urological surgeries and drawing on the technical strengths of our fellow medical experts, thereby promoting the progress and upgrading of high-end medical devices and providing better technical services for surgeons for the benefit of more patients, so as to fulfill the company’s founding aspiration to “Make Surgery Easier, Safer and Less Invasive”.